Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xyel Ofteno
- Development stage
- Unknown
- Lead developer
- Laboratorios Sophia
- Modality
- Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
Xyel Ofteno is an ophthalmic solution developed by Laboratorios Sophia S.A. de C.V. It is indicated for the temporary relief of dry eye symptoms, including burning, foreign body sensation, and ocular dryness caused by various conditions such as keratoconjunctivitis sicca, blepharoconjunctivitis, exposure keratitis, blepharitis, and mild ocular irritations. It also serves as an adjuvant to other topical ocular treatments to improve tear film quality. The drug contains chondroitin sulfate and xanthan gum, which work together to lubricate the ocular surface and provide a prolonged soothing effect.
- Brand names
- Xyel Ofteno
Beyond the preview
Go deeper on Xyel Ofteno.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xyel Ofteno.